Background illustration for clinical trials search

Paid Clinical Trials Orlando

Discover 1,006 paid clinical trials in Orlando, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Tracking Results of Ablations to Combat AF Registry Generation 2

for
Atrial Fibrillation
Location: Orlando FL, Tampa FL, Gainesville FL, Delray Beach FL,
Sponsor: AtriCure, Inc.

Sex: All

Age: 18+

Code: NCT05111015

Recruiting

Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial

for
Diabetes, End Stage Renal Disease
Location: Orlando FL, Dothan AL, Orangeburg SC, Greenville SC,
Sponsor: Sonavex, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06190717

Recruiting

A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System

for
Atrial Fibrillation
Location: Orlando FL, Jacksonville FL, Miami FL, Cincinnati OH,
Sponsor: Biosense Webster, Inc.

Sex: All

Age: 22+

Code: NCT07227532

Recruiting

SPYRAL GEMINI Pilot Study

for
Hypertension, Vascular Diseases, Cardiovascular Diseases,
Location: Orlando FL, Safety Harbor FL, Atlanta GA,
Sponsor: Medtronic Vascular

Sex: All

Age: 18 - 70+

Code: NCT06907147

Recruiting

Regeneration of Acutely Injured Nerves With Temporary Electrical Stimulation

for
Nerve Injury
Location: Orlando FL, Gainesville FL, New Orleans LA,
Sponsor: Epineuron Technologies Inc.

Sex: All

Age: 18 - 65

Code: NCT05721261

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

for
Carcinoma, Renal Cell, Advanced Renal Cell Carcinoma,
Location: Orlando FL, Jacksonville FL, Myrtle Beach SC,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07227415

Phase1, Phase2, Recruiting

Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

for
Advanced/Metastatic Non-Small Cell Lung Cancer,
Location: Orlando FL, Orange City FL, Coral Springs FL,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07227298

Phase1, Phase2, Recruiting

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

for
Cervical Cancer
Location: Orlando FL, Daytona Beach FL, Bradenton FL, Sarasota FL,
Sponsor: Pfizer

Sex: Female

Age: 18+

Code: NCT06952660

Recruiting

A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO

for
Neovascular Age-Related Macular Degeneration (NVAMD),
Location: Orlando FL, Jacksonville FL, Fort Lauderdale FL,
Sponsor: EyeBiotech Ltd.

Sex: All

Age: 18+

Code: NCT07205887

Phase2, Recruiting

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Orlando FL, Winter Haven FL, Tampa FL, Bayonet Point FL,
Sponsor: Apellis Pharmaceuticals, Inc.

Sex: All

Age: 60+

Code: NCT07215390

Phase2, Recruiting

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

for
Neovascular Age-Related Macular Degeneration (nAMD)
Location: Orlando FL, Tampa FL, Hudson FL, St. Petersburg FL,
Sponsor: 4D Molecular Therapeutics

Sex: All

Age: 50+

Code: NCT07064759

Phase3, Recruiting

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

for
Age-related Macular Degeneration (AMD), Geographic Atrophy (GA)
Location: Orlando FL, Winter Haven FL, Lakeland FL, Tampa FL,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 50 - 70+

Code: NCT06541704

Phase3, Recruiting

Randomized Trial of Percutaneous vs. Endoscopic Gallbladder Drainage

for
Acute Cholecystitis
Location: Orlando FL
Sponsor: Orlando Health, Inc.

Sex: All

Age: 18+

Code: NCT07696546

Recruiting

EUS Procedures Using RIVOS™ EUS Access Device

for
Pancreatic Fluid Collections, Biliary Obstruction,
Location: Orlando FL
Sponsor: Orlando Health, Inc.

Sex: All

Age: 18+

Code: NCT07696572

Recruiting

Randomized Trial of Next Generation Fluoroscopy System vs. Conventional Fluoroscopy System in Endoscopy

for
Radiation Exposure
Location: Orlando FL
Sponsor: Orlando Health, Inc.

Sex: All

Age: 18+

Code: NCT07594132

Recruiting

Strategic Timing of Endoscopic Interventions in Infected Necrotizing Pancreatitis

for
Pancreatitis, Acute Necrotizing
Location: Orlando FL
Sponsor: Orlando Health, Inc.

Sex: All

Age: 18+

Code: NCT07406698

Recruiting

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

for
Inflammatory Bowel Diseases, Crohn's Disease
Location: Orlando FL, Kissimmee FL, Miami FL, Palmetto Bay FL,
Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)

Sex: All

Age: 18 - 70+

Code: NCT06226883

Phase2, Recruiting

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

for
Ulcerative Colitis, Crohn's Disease
Location: Orlando FL, Kissimmee FL, Orange City FL,
Sponsor: Takeda

Sex: All

Age: 18 - 70+

Code: NCT06581328

Recruiting

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

for
Crohn's Disease
Location: Orlando FL, Kissimmee FL, Tampa FL, Dothan AL,
Sponsor: Takeda

Sex: All

Age: 18 - 70

Code: NCT06045754

Recruiting

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

for
Ulcerative Colitis, Ulcerative Colitis Chronic
Location: Orlando FL, Tampa FL, Miami FL, Chapel Hill NC,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT06598943

Phase2, Recruiting

Orlando, Florida has a well-developed healthcare system with several prominent medical research facilities, making it an important hub for a diverse array of clinical trials. Notable institutions such as the Orlando Health Cancer Institute and the University of Central Florida's College of Medicine are at the forefront of these research initiatives.

Each medical center in Orlando focuses on innovative studies across various fields, including oncology, cardiovascular health, and neurological disorders, positioning Orlando as a vital contributor in advancing medical research and treatment options.

Why choose Orlando for clinical trials?

Orlando offers a vast array of advantages for individuals considering participation in clinical trials. The city is home to a diverse population, which helps create a wide range of participants, enhancing the reliability and applicability of research findings.

Additionally, Orlando’s thriving healthcare ecosystem fosters an environment of innovation and collaboration, with a strong emphasis on advancing medical research and treatment. By participating in a clinical trial in Orlando, participants not only gain access to innovative therapies but also play a crucial role in advancing scientific knowledge.

Common conditions studied in Orlando

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Orlando